Expertise in
16
conditions

Jordi G. Esteve

Barcelona, CT, ES 
Expertise in
16
conditions
Barcelona, CT, ES 

Overview

Jordi Esteve practices practicing medicine in Barcelona, Spain.

Esteve is highly rated in 16 conditions, according to our data. Their clinical expertise encompasses Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Graft.

They are actively involved in clinical research, co-authoring 258 peer reviewed articles and participating in 2 clinical trials.

Locations

Barcelona, CT, Spain
Other Locations
Pi, CT, Spain
Madrid, MD, Spain
Badalona, CT 08916, Spain
Valencia, VC, Spain
Bellaterra, CT 08193, Spain
Zaragoza, AR 50009, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I-II, Multicentre, Open Label Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine, Plus Venetoclax and Quizartinib in Newly Diagnosed Acute Myeloid Leukemia Patients Aged Equal or More Than 60 Years Old Ineligible for Standard Induction Chemotherapy
A Phase I-II, Multicentre, Open Label Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine, Plus Venetoclax and Quizartinib in Newly Diagnosed Acute Myeloid Leukemia Patients Aged Equal or More Than 60 Years Old Ineligible for Standard Induction Chemotherapy
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drugs: Azacitidine, Venetoclax, Quizartinib, Cytarabine
Study Phase: Phase 1/Phase 2
Phase 2 Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity (A3B1) Conjugated With the Co-stimulatory Regions 4-1BB and CD3z (ARI-0001 Cells) in Patients With CD19+ Acute Lymphoid Leukemia Resistant or Refractory to Therapy
Phase 2 Study of the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity (A3B1) Conjugated With the Co-stimulatory Regions 4-1BB and CD3z (ARI-0001 Cells) in Patients With CD19+ Acute Lymphoid Leukemia Resistant or Refractory to Therapy
Enrollment Status: Unknown
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drug: ARI-0001 cells
Study Phase: Phase 2
View 1 Less Clinical Trial

258 Total Publications

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: August 31, 2026

Frequently Asked Questions about Jordi G. Esteve

Is Jordi G. Esteve a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Jordi G. Esteve is classified as an Elite expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jordi G. Esteve participate in research or clinical trials?

Yes. Jordi G. Esteve has published 258 articles and abstracts on conditions like Leukemia. You can view a list of Jordi G. Esteve's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Esteve's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile